Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of systemic cancer therapy. During disinhibiting the antitumor responses of immune system, ICIs may also cause unique immune-related adverse events (irAEs) which could affect any organ. Here, we report a rare case of sintilimab-in...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaxiang Ji, Chin-Hui Lai, Xiaowei Zhang, Hao Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501415/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846111705383305216
author Jiaxiang Ji
Jiaxiang Ji
Chin-Hui Lai
Chin-Hui Lai
Xiaowei Zhang
Xiaowei Zhang
Hao Hu
Hao Hu
author_facet Jiaxiang Ji
Jiaxiang Ji
Chin-Hui Lai
Chin-Hui Lai
Xiaowei Zhang
Xiaowei Zhang
Hao Hu
Hao Hu
author_sort Jiaxiang Ji
collection DOAJ
description Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of systemic cancer therapy. During disinhibiting the antitumor responses of immune system, ICIs may also cause unique immune-related adverse events (irAEs) which could affect any organ. Here, we report a rare case of sintilimab-induced ureteritis/cystitis in a 55-year-old male undergoing neoadjuvant chemo-immunotherapy for gastric cancer. The patient presented with severe renal colic, hematuria, and hydronephrosis. Antibiotic antispasmodic and nonsteroidal anti-inflammatory drug treatment failed to alleviate symptoms. The application of corticosteroid was negated for recent extirpative surgery under plan. Bilateral ureteral stenting effectively resolved the pain and improved renal function. The patient later successfully underwent laparoscopic radical gastrectomy with significant tumor regression in postoperative pathology. This case highlights ureteral stenting as a potential corticosteroid-free treatment option for ICI-induced ureteritis/cystitis.
format Article
id doaj-art-9c08f6078c0a4a75abae8fdb9a70a186
institution Kabale University
issn 1664-3224
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-9c08f6078c0a4a75abae8fdb9a70a1862024-12-23T06:38:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-12-011510.3389/fimmu.2024.15014151501415Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literatureJiaxiang Ji0Jiaxiang Ji1Chin-Hui Lai2Chin-Hui Lai3Xiaowei Zhang4Xiaowei Zhang5Hao Hu6Hao Hu7Department of Urology, Peking University People’s Hospital, Beijing, ChinaThe institute of applied lithotripsy technology, Peking University, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaThe institute of applied lithotripsy technology, Peking University, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaThe institute of applied lithotripsy technology, Peking University, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaThe institute of applied lithotripsy technology, Peking University, Beijing, ChinaImmune checkpoint inhibitors (ICIs) have revolutionized the treatment of systemic cancer therapy. During disinhibiting the antitumor responses of immune system, ICIs may also cause unique immune-related adverse events (irAEs) which could affect any organ. Here, we report a rare case of sintilimab-induced ureteritis/cystitis in a 55-year-old male undergoing neoadjuvant chemo-immunotherapy for gastric cancer. The patient presented with severe renal colic, hematuria, and hydronephrosis. Antibiotic antispasmodic and nonsteroidal anti-inflammatory drug treatment failed to alleviate symptoms. The application of corticosteroid was negated for recent extirpative surgery under plan. Bilateral ureteral stenting effectively resolved the pain and improved renal function. The patient later successfully underwent laparoscopic radical gastrectomy with significant tumor regression in postoperative pathology. This case highlights ureteral stenting as a potential corticosteroid-free treatment option for ICI-induced ureteritis/cystitis.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501415/fullimmune checkpoint inhibitors (ICIs)immune-related adverse events (irAEs)sintilimabureteritis/cystitisureteral stent
spellingShingle Jiaxiang Ji
Jiaxiang Ji
Chin-Hui Lai
Chin-Hui Lai
Xiaowei Zhang
Xiaowei Zhang
Hao Hu
Hao Hu
Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
Frontiers in Immunology
immune checkpoint inhibitors (ICIs)
immune-related adverse events (irAEs)
sintilimab
ureteritis/cystitis
ureteral stent
title Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
title_full Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
title_fullStr Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
title_full_unstemmed Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
title_short Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
title_sort immune related adverse events with renal colic as the main manifestation a case report of sintilimab induced ureteritis cystitis treated by ureteral stent and review of the literature
topic immune checkpoint inhibitors (ICIs)
immune-related adverse events (irAEs)
sintilimab
ureteritis/cystitis
ureteral stent
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501415/full
work_keys_str_mv AT jiaxiangji immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT jiaxiangji immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT chinhuilai immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT chinhuilai immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT xiaoweizhang immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT xiaoweizhang immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT haohu immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature
AT haohu immunerelatedadverseeventswithrenalcolicasthemainmanifestationacasereportofsintilimabinducedureteritiscystitistreatedbyureteralstentandreviewoftheliterature